Abstract
To characterise prevalence of traditional cardiovascular disease (CVD) risk factors, assess CVD risk and examine the effect of simulated interventions on CVD risk among HIV-infected Asian Indians. Cross-sectional data between September 2015 and July 2016 wer used to describe the prevalence of CVD risk factors. Five risk scores (Framingham, Data Collection on Adverse Effects of Anti-HIV Drugs Study (D:A:D), Atherosclerotic Cardiovascular, QRISK2 and Ramathibodi-Electricity Generating Authority of Thailand were used to estimate CVD risk. The effect of seven sensitivity analyses: smoking prevention; diabetes prevention; optimal blood pressure and dyslipidaemia control (total cholesterol, high-density lipoprotein (HDL)); CD4 augmentation and a combination of the scenarios on the median cumulative D:A:D CVD scores were assessed. Of 402 enrolled, 56% were women, median age was 40 years (IQR: 35-45 years) and median time-updated CD4 counts were 378 cells/μL (IQR: 246-622). Fifty-five and 28% had ever been screened for hypertension and diabetes, respectively prior to enrolment. The prevalence of diabetes, hypertension, hypercholesterolaemia, low HDL, previous and current smokers were 9%, 22%, 20%, 39%, 14% and 4%, respectively. Thirty-...Continue Reading
References
Aug 13, 2002·AIDS·A MocroftUNKNOWN EuroSIDA study group
Jan 18, 2007·JAMA : the Journal of the American Medical Association·Prashant JoshiSalim Yusuf
Apr 26, 2007·The Journal of Clinical Endocrinology and Metabolism·Virginia A TriantSteven K Grinspoon
Jul 7, 2009·BMC Cardiovascular Disorders·Rajeev GuptaR M Pandey
Dec 15, 2010·BMJ : British Medical Journal·Julia Hippisley-CoxPeter Brindle
Jan 22, 2011·HIV Medicine·K PetoumenosMg Law
Jun 15, 2011·Best Practice & Research. Clinical Endocrinology & Metabolism·Paul W Hruz
Oct 1, 2011·Diabetologia·R M AnjanaUNKNOWN ICMR–INDIAB Collaborative Study Group
Mar 6, 2013·JAMA Internal Medicine·Matthew S FreibergAmy C Justice
Mar 19, 2013·International Journal of Health Geographics·Ambarish VaidyanathanJudith R Qualters
Oct 29, 2013·Journal of the American College of Cardiology·Joseph A Ladapo, Keith S Goldfeld
Nov 14, 2013·Journal of the American Pharmacists Association : JAPhA
Nov 19, 2013·Journal of the American College of Cardiology·David C GoffPeter W F Wilson
Apr 2, 2014·Annals of Internal Medicine·Wendy S PostLisa P Jacobson
Jul 9, 2014·PloS One·Joel C Miller
Aug 1, 2014·Journal of Human Hypertension·A BhansaliR Pradeepa
Aug 1, 2014·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·N PhinUNKNOWN Incident Control Team
Jan 15, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Anne-Lise PaisibleMatthew S Freiberg
Jun 19, 2015·The Journal of Clinical Endocrinology and Metabolism·Suman SrinivasaSteven K Grinspoon
Jul 21, 2015·The New England Journal of Medicine·UNKNOWN INSIGHT START Study GroupJames D Neaton
Aug 19, 2015·Progress in Cardiovascular Diseases·Evan L O'KeefeCarl J Lavie
Dec 23, 2015·AIDS Research and Therapy·Felistas MashinyaRobert Colebunders
Feb 10, 2016·Rheumatology·Eirik IkdahlAnne Grete Semb
Apr 20, 2016·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Priya LallAdeeba Kamarulzaman
Apr 24, 2016·Heart·Justin R KingeryRobert N Peck
Jun 30, 2016·Journal of the American Heart Association·Hossein BahramiWendy S Post
Jul 20, 2016·HIV Medicine·T C DoK Ruxrungtham
Citations
Jul 3, 2018·Frontiers in Immunology·Damariz Marín-PalmaJuan C Hernandez
Nov 17, 2020·AIDS Research and Treatment·Sneha Deepak MallyaKavitha Saravu
Jul 15, 2021·Medicine·Fahim PyaraliClaudia Martinez
Oct 28, 2021·HIV Medicine·Derek LarsonRobert Deiss